(Q46845401)

25 December 2017

title

Autoantibody-catalyzed hydrolysis of amyloid beta peptide (English)

1 reference

25 December 2017

1 reference

5

1 reference

25 December 2017

Paul A. Ramsland

8

1 reference

25 December 2017

author name string

Hiroaki Taguchi

1

1 reference

25 December 2017

Stephanie Planque

2

1 reference

25 December 2017

Yasuhiro Nishiyama

3

1 reference

25 December 2017

Jindrich Symersky

4

1 reference

25 December 2017

Paul Szabo

6

1 reference

25 December 2017

Robert P Friedland

7

1 reference

25 December 2017

Allen B Edmundson

9

1 reference

25 December 2017

Marc E Weksler

10

1 reference

25 December 2017

Sudhir Paul

11

1 reference

25 December 2017

language of work or name

English

0 references

publication date

17 December 2007

1 reference

25 December 2017

Journal of Biological Chemistry

published in

1 reference

25 December 2017

volume

283

1 reference

25 December 2017

issue

8

1 reference

25 December 2017

page(s)

4714-4722

1 reference

25 December 2017

A beta oligomers - a decade of discovery

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Secretase as a target for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Immunotherapy as a therapeutic treatment for neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Current progress in beta-amyloid immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Degradation of beta-amyloid by proteolytic antibody light chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Specific degradation of H. pylori urease by a catalytic antibody light chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Ontogeny of proteolytic immunity: IgM serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

ZDOCK predictions for the CAPRI challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

A network dysfunction perspective on neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Clearance of amyloid-beta by circulating lipoprotein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Phosphonate ester probes for proteolytic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Alzheimer disease and cerebrovascular pathology: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Vessel ultrastructure in APP23 transgenic mice after passive anti-Abeta immunotherapy and subsequent intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Antibodies as defensive enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Catalytic activity of antibodies against factor VIII in patients with hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Somatic hypermutation of an immunoglobulin mu heavy chain transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

Binding of trypsin to fibrillar amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707983200

21 January 2018

Identifiers

DOI

10.1074/JBC.M707983200

1 reference

25 December 2017

PubMed ID

18086674

1 reference

25 December 2017